Nihon Kohden (OTCMKTS:NHNKY) Shares Down 1.8% - Here's Why

Key Points

• Nihon Kohden Corporation shares fell by 1.8% to $11.39, with a trading volume that was 43% below the average daily volume.
• The company reported earnings of $0.18 per share for the last quarter, with total revenue of $439.11 million.
• Nihon Kohden has a market capitalization of $1.95 billion and a PE ratio of 20.33.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) shares were down 1.8% on Monday . The stock traded as low as $11.16 and last traded at $11.39. Approximately 3,244 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 5,722 shares. The stock had previously closed at $11.59.

Nihon Kohden Trading Down 1.8%

The firm has a market capitalization of $1.95 billion, a PE ratio of 20.33 and a beta of 0.34. The firm has a 50-day moving average of $12.17 and a two-hundred day moving average of $13.16.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $0.18 earnings per share for the quarter. The business had revenue of $439.11 million for the quarter. Nihon Kohden had a return on equity of 7.20% and a net margin of 6.23%.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.